FOLLOW US

Endocrine Research Updates

For Medical Professionals

People with type 2 diabetes can safely take a proton pump inhibitor long-term..
Given the influences of the gut microbiome, researchers explored the potential benefits and adverse effects of long-term use of PPIs on the pancreas and liver in people with type 2 diabetes.
Researchers explored concerns regarding possible adverse effects of long-term use of proton pump inhibitors in people with type 2 diabetes.
Treating hypogonadism with Testosterone can prevent progression of diabetes.
Testosterone replacement halted the progression to diabetes in 90% of men who had hypogonadism, achieving improvement risk factor measures including body weight and lipids, in men who had a diagnosis of prediabetes prior to treatment.
Diabetes is common in men with hypogonadism. If diagnosed and treated with testosterone, diabetes and its common complications can be prevented.
New diabetes devices meet patient need for more reliable device design.
A series of recent Food and Drug Administration actions reflect a desire to meet consumer demands for ease of diabetes product use across multiple platforms, and more..
FDA clears diabetes devices that fulfill patient desires for fully automate interoperability between glucose management products to work in real life settings.
Female pattern hair loss has a markedly different pattern than occurs in men.
Female pattern hair loss is a bonafide quality of life issue that deserves clinical action based on recently introduced evidence based recommendations that may or may not arise from androgen excess.
Most pituitary tumors are benign but the rare cancerous ones requires vigilance.
Review study raised questions about identification and treatment of rare pituitary adenomas. For now, individualized management should remain the standard of care.
Obesity is often difficult to overcome due to feelings of shame.
Given the continuing rise in obesity and associated chronic conditions, having the tools to help patients will matter little if there is no patient-provider acknowledgement of the problem. Retool your practice for better weight control outcomes in your patients.
For patients receiving transgender hormone therapy, monitor for CVD.
For individuals receiving transgender hormone therapy, the focus of clinical care should be on reducing known cardiovascular risk factors to support optimal patient outcomes.
Patients receiving transgender hormone therapy, especially transgender women faced an increased risk for CVD events, which can be managed with usual care.
GMI becomes key blood glucose value for patients with CGMs.
Validation of the Glucose Management Indicator (GMI) as an acceptable replacement for “estimated HbA1c” in patients using continuous glucose monitoring grows with the endorsement of the FDA.
Know the new diabetes devices becoming available and for which patients.
Given the avalanche of app approvals, product updates, and study findings, here’s what to watch for as the future of clinical diabetes management unfolds.
Digital food logs improve the experience and keep people going to lose weight.
Encouraging your patients to keep track of their food intake should be encouraged to promote suistainable weight loss given the easy access to online tools and smartphone apps that cut down on time.
Using a digital food tracker or mobile food journaling app for as little as 15 minutes daily promises meaningful weight loss for those who stick with it.
Know the 3 reasons that post-thyroidectomy patients go back to the hospital.
There are several conditions that represent the majority of cases requiring a return to the hospital following post-thyroidectomy procedures. By assessing patients for these anticipatable concerns, clinicians have an opportunity to reduce the rate of readmissions in the first few days after discharge.
Cushing's disease is another example of a pro-inflammatory condition.
In patients with Cushing’s disease, possible long-term exposure to glucocorticoids may lead to an altered adipose structure increasing systemic inflammation, which may be behind the development of insulin resistance, obesity, and cardiovascular disease.
A child's home environment provides clues to risk of obesity in adulthood.
Gaining insights from the patient’s childhood environment may prove meaningful in developing more effective weight management strategies in adults.
Drawing on insights from the patient’s childhood environment may prove meaningful in developing more effective weight management strategies in adults.
Don't self-diagnose hypothyroidism and insist on treatment—ask your doctor.
Findings from a pair of studies provide sufficient evidence to challenge any need to prescribe levothyroxine for mild hypothyroidism in nearly all patients except those planning a pregnancy.
Every person will increase their health by walking even 2-3 times a week.
Visceral fat, which accumulates in the abdominal cavity, has a greater adverse effect on health than subcutaneous adiposity that shapes our appearance. Exercise seems to deliver the most effective means of ridding the body of this “hidden” fat, and the risks linked to most common chronic diseases.
Soluble fiber can reduce glucose dramatically in people with type 2 diabetes.
More evidence that the higher the dietary fiber intake, the greater the health-promoting benefits, and soluble fiber alone may achieve reduce hemoglobin A1c levels substantially.
People with thyroid disease appear at increased risk for AF.
Evidence tying an increased risk of cardiovascular events, particularly AF, in people with hypo- and hyperthyroidism, is gaining strength.
Technology upgrades and enhancements approved by the FDA for diabetes care.
A brief overview of several technology enhancements and clinical practice tools to watch for and consider using in the coming months—January edition.
Cognitive training can help obese individuals forgo problem foods.
Learning cognitive strategies in brief sessions showed potential to decrease cravings for unhealthy foods, prompt better food choices in people with elevated BMI.
Understanding of bone response to dual drugs informs osteoporosis management.
Two studies advance osteoporosis understand—Statin users had better cortical bone properties, while bone density changes were favorable when dual therapy: teriparatide and abaloparatide
close X
SHOW MAIN MENU
SHOW SUB MENU